<DOC>
	<DOCNO>NCT00984880</DOCNO>
	<brief_summary>The primary purpose study assess safety tolerability AZD3043 follow administration single ascend bolus dos ( Part A ) single ascend bolus dos follow infusion ( Part B ) .</brief_summary>
	<brief_title>Study Assess Safety , Tolerability , Pharmacokinetics Pharmacodynamics AZD3043</brief_title>
	<detailed_description />
	<criteria>Subjects suitable vein cannulation repeat venepuncture Predose assessment judge without remark investigator Have body mass index ( BMI ) 18 30 kg/m2 weigh least 50 kg 100 kg Abnormal vital sign , 15 minute supine rest , define follow : Systolic blood pressure &gt; 140 mm Hg Diastolic blood pressure &gt; 90 mm Hg Heart rate â‰¤45 &gt; 85 beat per minute Lack normal phenotype BuChE ( Butyrylcholinesterase )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Sedation</keyword>
	<keyword>anaesthesia</keyword>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
</DOC>